Immunization of dogs and cats with a DNA vaccine against rabies virus

Vaccine

Volumn 17, Issue 9-10, 1999, Pages 1109-1116

  Osorio, J E ^a   Tomlinson, C C ^a   Frank, R S ^a   Haanes, E J ^a   Rushlow, K ^a   Haynes, J R ^a   Stinchcomb, D T ^a  

^a HESKA CORPORATION   (United States)

Author keywords

Cats; DNA vaccines; Dogs; Mice; Rabies

Indexed keywords

RABIES VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; CAT; DOG; GENE TARGETING; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; RABIES; SEROCONVERSION; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, VIRAL; CAT DISEASES; CATS; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; RABIES; RABIES VACCINES; RABIES VIRUS; VACCINATION; VACCINES, DNA;

EID: 0033525601     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00328-4     Document Type: Article

References (41)

1. King A.A., Turner G.S. Rabies: a review. J Comp Pathol. 108:1993;1-39.
2. Fu Z.F. Rabies and rabies research: past, present and future. Vaccine. 15 (Suppl.):1997;S20-S24.
3. Kihm U., Flamand A., Pastoret P.P., Peterhans E. Round table on epidemiology and control of fox rabies. Vet Microbiol. 33:1992;297-301.
4. Kieny M.P., Desmettre P., Soulebot J.P., Lathe R. Rabies vaccine: traditional and novel approaches. Prog Vet Microbiol Immunol. 3:1987;73-111.
5. Koutchoukali M.A., Blancou J., Chappuis G.et al. Serological response of the dog after primary antirabies vaccination using adjuvant or non-adjuvant vaccines. Ann Rech Vet. 16:1985;345-349.
6. Perez O., Paolazzi C.C. Production methods for rabies vaccine. J Ind Microbiol Biotechnol. 18:1997;340-347.
7. Schneider L.G. Rabies virus vaccines. Dev Biol Stand. 84:1995;49-54.
8. Rudmann D.G., Van Alstine W.G., Doddy F., Sandusky G.E., Barkdull T., Janovitz E.B. Pulmonary and mediastinal metastases of a vaccination-site sarcoma in a cat. Vet Pathol. 33:1996;466-469.
9. Dubielzig R.R., Hawkins K.L., Miller P.E. Myofibroblastic sarcoma originating at the site of rabies vaccination in a cat. J Vet Diagn Invest. 5:1993;637-638.
10. Sureau P., Perrin P. The use of immunosome technology for vaccines against rabies and other viral diseases. Eur J Epidemiol. 5:1989;275-278.
11. Wunner W.H., Dietzschold B., Curtis P.J., Wiktor T.J. Rabies subunit vaccines. J Gen Virol. 64:1983;1649-1656.
12. Paoletti E. Applications of pox virus vectors to vaccination: an update. Proc Natl Acad Sci USA. 93:1996;11349-11353.
13. Xiang Z.Q., Yang Y., Wilson J.M., Ertl H.C. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology. 219:1996;220-227.
14. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.C. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199:1994;132-140.
15. Xiang Z.Q., Spitalnik S.L., Cheng J., Erikson J., Wojczyk B., Ertl H.C. Immune responses to nucleic acid vaccines to rabies virus. Virology. 209:1995;569-579.
16. Ray N.B., Ewalt L.C., Lodmell D.L. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Vaccine. 15:1997;892-895.
17. Coll J.M. The glycoprotein G of rhabdoviruses. Arch Virol. 140:1995;827-851.
18. Fujii H., Mannen K., Takita-Sonoda Y., Hirai K., Cruz-Abrenica M.S., Kawano Y., Nishizono A., Mifune K. Target cells of cytotoxic T lymphocytes directed to the individual structural proteins of rabies virus. Microbiol Immunol. 38:1994;721-726.
19. Wunner W.H., Larson J.K., Dietzschold B., Smith C.L. The molecular biology of rabies viruses. Rev Infect Dis. 10 (Suppl 4.):1988;S771-S784.
20. Anilionis A., Wunner W.H., Curtis P.J. Structure of the glycoprotein gene in rabies virus. Nature. 294:1981;275-278.
21. Dietzschold B., Wiktor T.J., Wunner W.H., Varrichio A. Chemical and immunological analysis of the rabies soluble glycoprotein. Virology. 124:1983;330-337.
22. Cox J.H., Dietzschold B., Schneider L.G. Rabies virus glycoprotein. II. Biological and serological characterization. Infect Immun. 16:1977;754-759.
23. Donnelly J., Ulmer J., Shiver J., Liu M. DNA vaccines. Annu Rev Immunol. 15:1997;617-648.
24. Robinson H. Nucleic acid vaccines: an overview. Vaccine. 15:1997;778-785.
25. Corr M, Lee D, Carson D, Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. 1996;184:1555-1560.
26. Barry M., Johnston S. Biological features of genetic immunization. Vaccine. 15:1997;788-791.
27. Donnelly J.J., Friedman A., Ulmer J.B., Liu M.A. Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination. Vaccine. 15:1997;865-868.
28. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., Callan R., Hinshaw V.S., Swain W.F. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J Virol. 72:1998;1491-1496.
29. Gerdts V., Jons A., Makoschey B., Visser N., Mettenleiter T.C. Protection of pigs against Aujeszky's disease by DNA vaccination. J Gen Virol. 78:1997;2139-2146.
30. Ward G., Rieder E., Mason P.W. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine. J Virol. 71:1997;7442-7447.
31. Schrijver R.S., Langedijk J.P., Keil G.M., Middel W.G., Maris-Veldhuis M., Van Oirschot J.T., Rijsewijk F.A. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV. Vaccine. 15:1997;1908-1916.
32. Liu M., McClements W., Ulmer J., Shiver J., Donnelly J. Immunization of non-human primates with DNA vaccines. Vaccine. 15:1997;909-912.
33. Rosner B. Fundamentals of biostatistics. 4th ed. Belmont, CA: Duxbury Press, 1995. p. 682.
34. Smith JS, Yager PA, Baer GM. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody. In: Meslin F, Kaplan MM, Koprowski H, editors. Laboratory techniques in rabies. World Health Organization: Geneva, 1996. p. 181-9.
35. Raz E., Carson D.A., Parker S.E.et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA. 91:1994;9519-9523.
36. 1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA. 93:1996;5141-5145.
37. Sato Y., Roman M., Tighe H.et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
38. Feltquante D., Heaney S., Webster R., Robinson H. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. Immunology. 158:1997;2278-2284.
39. Pertmer T., Eisenbraun M., McCabe D., Prayaga S., Fuller D., Haynes J. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T-lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine. 13:1995;1427-1430.
40. Roman M., Martin-Orozco E., Goodman J.et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 3:1997;849-854.
41. Davis H., Michel M., Mancini M., Schleef M., Whalen R. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine. 12:1994;1503-1509.